Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and jnj 26854165

gefitinib has been researched along with jnj 26854165 in 3 studies

Compound Research Comparison

Studies
(gefitinib)		Trials
(gefitinib)		Recent Studies (post-2010)
(gefitinib)		Studies
(jnj 26854165)		Trials
(jnj 26854165)		Recent Studies (post-2010) (jnj 26854165)
5,2315662,91918117

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Chan, CH; Chan, HL; Chang, SJ; Chen, HY; Chen, YJ; Chou, HC; Chuang, YJ; Kuo, WH; Lai, ZY; Li, JM; Liao, EC; Shih, CC; Tsai, YT; Wang, YS; Wei, YS; Yeo, HY1
Chang, SJ; Chuang, YJ; Lai, ZY; Tsai, KY1

Other Studies

3 other study(ies) available for gefitinib and jnj 26854165

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Proteomic investigating the cooperative lethal effect of EGFR and MDM2 inhibitors on ovarian carcinoma.
    Archives of biochemistry and biophysics, 2018, Jun-01, Volume: 647

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Synergism; ErbB Receptors; Female; Gefitinib; Humans; Ovarian Neoplasms; Proteome; Proteomics; Proto-Oncogene Proteins c-mdm2; Tryptamines

2018
Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor.
    International journal of molecular sciences, 2021, Aug-16, Volume: 22, Issue:16

    Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cystadenocarcinoma, Serous; ErbB Receptors; Female; Gain of Function Mutation; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Signal Transduction; Tryptamines; Tumor Suppressor Protein p53; Up-Regulation

2021